Hamburg Sets as FDA Priority Flexing Enforcement Muscle

摘要

The FDA is pursuing more flexible enforcement mechanisms and new state government partnerships to handle situations such as the recent contamination of GlaxoSmithKline's (GSK) pediatric Rotarix vaccine, Commissioner Margaret Hamburg says.